175 related articles for article (PubMed ID: 37258049)
1. Early recurrence of focal segmental glomerulosclerosis in a kidney transplant recipient with
Acharya R; Upadhyay K
BMJ Case Rep; 2023 May; 16(5):. PubMed ID: 37258049
[No Abstract] [Full Text] [Related]
2. Donor's APOL1 Risk Genotype and "Second Hits" Associated With De Novo Collapsing Glomerulopathy in Deceased Donor Kidney Transplant Recipients: A Report of 5 Cases.
Chang JH; Husain SA; Santoriello D; Stokes MB; Miles CD; Foster KW; Li Y; Dale LA; Crew RJ; Cohen DJ; Kiryluk K; Gharavi AG; Mohan S
Am J Kidney Dis; 2019 Jan; 73(1):134-139. PubMed ID: 30054024
[TBL] [Abstract][Full Text] [Related]
3. Transplantation With APOL1 Risk Variant Kidney May Be Associated With Lifetime Risk for Recurrence of Focal Segmental Glomerulosclerosis: A Case Report and Review of Literature.
Mirza A; Kowalewska J; McCune T
Transplant Proc; 2019 Nov; 51(9):3077-3079. PubMed ID: 31324484
[TBL] [Abstract][Full Text] [Related]
4. Does copy number variation of APOL1 gene affect the susceptibility to focal segmental glomerulosclerosis?
Peng T; Li G; Zhong X; Wang L
Ren Fail; 2017 Nov; 39(1):500-504. PubMed ID: 28494221
[TBL] [Abstract][Full Text] [Related]
5. Donor APOL1 high-risk genotypes are associated with increased risk and inferior prognosis of de novo collapsing glomerulopathy in renal allografts.
Santoriello D; Husain SA; De Serres SA; Bomback AS; Crew RJ; Vasilescu ER; Serban G; Campenot ES; Kiryluk K; Mohan S; Hawkins GA; Hicks PJ; Cohen DJ; Radhakrishnan J; Stokes MB; Markowitz GS; Freedman BI; D'Agati VD; Batal I
Kidney Int; 2018 Dec; 94(6):1189-1198. PubMed ID: 30287079
[TBL] [Abstract][Full Text] [Related]
6. APOL1 risk genotype in European steroid-resistant nephrotic syndrome and/or focal segmental glomerulosclerosis patients of different African ancestries.
Gribouval O; Boyer O; Knebelmann B; Karras A; Dantal J; Fourrage C; Alibeu O; Hogan J; Dossier C; Tête MJ; Antignac C; Servais A
Nephrol Dial Transplant; 2019 Nov; 34(11):1885-1893. PubMed ID: 29992269
[TBL] [Abstract][Full Text] [Related]
7. De Novo Focal and Segmental Glomerulosclerosis After COVID-19 in a Patient With a Transplanted Kidney From a Donor With a High-risk APOL1 Variant.
Oniszczuk J; Moktefi A; Mausoleo A; Pallet N; Malard-Castagnet S; Fourati S; El Karoui K; Sahali D; Stehlé T; Boueilh A; Verpont MC; Matignon M; Buob D; Grimbert P; Audard V
Transplantation; 2021 Jan; 105(1):206-211. PubMed ID: 32852403
[TBL] [Abstract][Full Text] [Related]
8. APOL1 genotype-associated morphologic changes among patients with focal segmental glomerulosclerosis.
Zee J; McNulty MT; Hodgin JB; Zhdanova O; Hingorani S; Jefferson JA; Gibson KL; Trachtman H; Fornoni A; Dell KM; Reich HN; Bagnasco S; Greenbaum LA; Lafayette RA; Gipson DS; Brown E; Kretzler M; Appel G; Sambandam KK; Tuttle KR; Chen D; Atkinson MA; Hogan MC; Kaskel FJ; Meyers KE; O'Toole J; Srivastava T; Sethna CB; Hladunewich MA; Lin JJ; Nast CC; Derebail VK; Patel J; Vento S; Holzman LB; Athavale AM; Adler SG; Lemley KV; Lieske JC; Hogan JJ; Gadegbeku CA; Fervenza FC; Wang CS; Matar RB; Singer P; Kopp JB; Barisoni L; Sampson MG
Pediatr Nephrol; 2021 Sep; 36(9):2747-2757. PubMed ID: 33646395
[TBL] [Abstract][Full Text] [Related]
9. APOL1 risk variants affect podocyte lipid homeostasis and energy production in focal segmental glomerulosclerosis.
Ge M; Molina J; Ducasa GM; Mallela SK; Varona Santos J; Mitrofanova A; Kim JJ; Liu X; Sloan A; Mendez AJ; Banerjee S; Liu S; Szeto HH; Shin MK; Hoek M; Kopp JB; Fontanesi F; Merscher S; Fornoni A
Hum Mol Genet; 2021 Apr; 30(3-4):182-197. PubMed ID: 33517446
[TBL] [Abstract][Full Text] [Related]
10. Identification of Novel Genetic Risk Factors for Focal Segmental Glomerulosclerosis in Children: Results From the Chronic Kidney Disease in Children (CKiD) Cohort.
Durand A; Winkler CA; Vince N; Douillard V; Geffard E; Binns-Roemer E; Ng DK; Gourraud PA; Reidy K; Warady B; Furth S; Kopp JB; Kaskel FJ; Limou S
Am J Kidney Dis; 2023 Jun; 81(6):635-646.e1. PubMed ID: 36623684
[TBL] [Abstract][Full Text] [Related]
11.
Zhang JY; Wang M; Tian L; Genovese G; Yan P; Wilson JG; Thadhani R; Mottl AK; Appel GB; Bick AG; Sampson MG; Alper SL; Friedman DJ; Pollak MR
Proc Natl Acad Sci U S A; 2018 Mar; 115(13):3446-3451. PubMed ID: 29531077
[TBL] [Abstract][Full Text] [Related]
12. APOL1 in an ethnically diverse pediatric population with nephrotic syndrome: implications in focal segmental glomerulosclerosis and other diagnoses.
Watanabe A; Guaragna MS; Belangero VMS; Casimiro FMS; Pesquero JB; de Santis Feltran L; Palma LMP; Varela P; de Menezes Neves PDM; Lerario AM; de Souza ML; de Mello MP; de Brito Lutaif ACG; Ferrari CR; Sampson MG; Onuchic LF; Nogueira PCK
Pediatr Nephrol; 2021 Aug; 36(8):2327-2336. PubMed ID: 33585978
[TBL] [Abstract][Full Text] [Related]
13. Strong protective effect of the APOL1 p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney disease.
Gupta Y; Friedman DJ; McNulty MT; Khan A; Lane B; Wang C; Ke J; Jin G; Wooden B; Knob AL; Lim TY; Appel GB; Huggins K; Liu L; Mitrotti A; Stangl MC; Bomback A; Westland R; Bodria M; Marasa M; Shang N; Cohen DJ; Crew RJ; Morello W; Canetta P; Radhakrishnan J; Martino J; Liu Q; Chung WK; Espinoza A; Luo Y; Wei WQ; Feng Q; Weng C; Fang Y; Kullo IJ; Naderian M; Limdi N; Irvin MR; Tiwari H; Mohan S; Rao M; Dube GK; Chaudhary NS; Gutiérrez OM; Judd SE; Cushman M; Lange LA; Lange EM; Bivona DL; Verbitsky M; Winkler CA; Kopp JB; Santoriello D; Batal I; Pinheiro SVB; Oliveira EA; Simoes E Silva AC; Pisani I; Fiaccadori E; Lin F; Gesualdo L; Amoroso A; Ghiggeri GM; D'Agati VD; Magistroni R; Kenny EE; Loos RJF; Montini G; Hildebrandt F; Paul DS; Petrovski S; Goldstein DB; Kretzler M; Gbadegesin R; Gharavi AG; Kiryluk K; Sampson MG; Pollak MR; Sanna-Cherchi S
Nat Commun; 2023 Nov; 14(1):7836. PubMed ID: 38036523
[TBL] [Abstract][Full Text] [Related]
14. Recurrent Focal Segmental Glomerulosclerosis After Kidney Transplantation in African Americans: Review of the Current Evidence.
Theophilus UI; John JR; Ihab S; Ahmed H
Exp Clin Transplant; 2021 Dec; 19(12):1245-1256. PubMed ID: 34269655
[TBL] [Abstract][Full Text] [Related]
15. APOL1 risk variants and the development of HIV-associated nephropathy.
Goyal R; Singhal PC
FEBS J; 2021 Oct; 288(19):5586-5597. PubMed ID: 33340240
[TBL] [Abstract][Full Text] [Related]
16. APOL1-Associated Collapsing Focal Segmental Glomerulosclerosis in a Patient With Stimulator of Interferon Genes (STING)-Associated Vasculopathy With Onset in Infancy (SAVI).
Abid Q; Best Rocha A; Larsen CP; Schulert G; Marsh R; Yasin S; Patty-Resk C; Valentini RP; Adams M; Baracco R
Am J Kidney Dis; 2020 Feb; 75(2):287-290. PubMed ID: 31601430
[TBL] [Abstract][Full Text] [Related]
17. Clinical phenotype of APOL1 nephropathy in young relatives of patients with end-stage renal disease.
Anyaegbu EI; Shaw AS; Hruska KA; Jain S
Pediatr Nephrol; 2015 Jun; 30(6):983-9. PubMed ID: 25530085
[TBL] [Abstract][Full Text] [Related]
18. FSGS and COVID-19 in Non-African American Patients.
Medina E; Rueda C; Batlle D
Kidney360; 2023 May; 4(5):687-699. PubMed ID: 37229730
[TBL] [Abstract][Full Text] [Related]
19. Focal Segmental Glomerulosclerosis.
Rosenberg AZ; Kopp JB
Clin J Am Soc Nephrol; 2017 Mar; 12(3):502-517. PubMed ID: 28242845
[TBL] [Abstract][Full Text] [Related]
20. The role of HLA antigens in recurrent primary focal segmental glomerulosclerosis.
Batal I; Khairallah P; Weins A; Andeen NK; Stokes MB
Front Immunol; 2023; 14():1124249. PubMed ID: 36911713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
